FRESENIUS KABI DEUTSCHLAND GMBH — Oxaliplatin Importer Profile
Pharmaceutical Importer · #1 buyer for Oxaliplatin · $9.0M import value · 362 shipments · GERMANY · DGFT Verified
FRESENIUS KABI DEUTSCHLAND GMBH is the #1 importer of Oxaliplatin from India with $9.0M in import value and 362 verified shipments. FRESENIUS KABI DEUTSCHLAND GMBH holds a 21.5% market share in Oxaliplatin imports based in GERMANY. The company sources from 1 verified supplier across 278 formulations shipped to 1 country. Overall, FRESENIUS KABI DEUTSCHLAND GMBH imports 10 pharmaceutical products worth $65.5M across 2 therapeutic categories.
FRESENIUS KABI DEUTSCHLAND GMBH — Oxaliplatin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Oxaliplatin to FRESENIUS KABI DEUTSCHLAND GMBH?
Verified from 362 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| FRESENIUS KABI ONCOLOGY LIMITED | $9.0M | 362 | 100.0% |
FRESENIUS KABI DEUTSCHLAND GMBH sources Oxaliplatin from 1 verified Indian supplier based on 362 customs records. The primary supplier is FRESENIUS KABI ONCOLOGY LIMITED accounting for 100.0% of imports.
How Does FRESENIUS KABI DEUTSCHLAND GMBH Compare to Nearest Oxaliplatin Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | FRESENIUS KABI DEUTSCHLAND GMBH ★ | GERMANY | $10.0M | 362 | $27.7K |
| 3 | PHARMACIE CENTRALE DES HOPITAUX | ALGERIA | $2.3M | 61 | $38.4K |
| 4 | YUSEN LOGISTICS BENELUX BELGIUM | BELGIUM | $2.2M | 94 | $23.8K |
FRESENIUS KABI DEUTSCHLAND GMBH ranks #1 among 693 Oxaliplatin importers from India. Average shipment value of $27.7K compared to the market average of $29.9K. The closest competitors by value are PHARMACIE CENTRALE DES HOPITAUX and YUSEN LOGISTICS BENELUX BELGIUM.
Where Does FRESENIUS KABI DEUTSCHLAND GMBH Import Oxaliplatin To?
Destination countries from 362 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $9.0M | 362 | 100.0% |
FRESENIUS KABI DEUTSCHLAND GMBH imports Oxaliplatin to 1 country. The primary destination is GERMANY receiving 100.0% of shipments worth $9.0M.
What Oxaliplatin Formulations Does FRESENIUS KABI DEUTSCHLAND GMBH Import?
| Formulation | Value | Shipments |
|---|---|---|
| OXALIPLATIN KABI INJ.200MG/40ML VIAL B.N | $607.6K | 15 |
| OXALIPLATIN KABI INJ.200MG/40ML VIAL(ITE | $286.2K | 11 |
| OXALIPLATINE FRESENIUS KABI INJ.200MG/40 | $190.8K | 9 |
| OXALIPLATIN KABI INJ.100MG/20ML VIAL B.N | $170.7K | 9 |
| OXALIPLATIN INJ. 200MG/40ML VIAL BATCH NO. 87250023AA, MFG. DT. 01/2025, EXP. DT. 12/2026 | $136.0K | 3 |
| OXALIPLATINE KABI INJ.200MG/40ML VIAL B. | $130.9K | 4 |
| OXALIPLATIN FRESENIUS KABI INJ.200MG/40M | $129.2K | 6 |
| OXALIPLATIN INJ.200MG/40ML VIAL B.NO.872 | $100.0K | 2 |
| OXALIPLATIN KABI INJ. 200MG/40ML VIAL BATCH NO. 87250022AA, MFG. DT. 01/2025, EXP. DT. 12/2026 | $100.0K | 2 |
| OXALIPLATIN KABI INJ.100MG/20ML VIAL(ITE | $92.0K | 4 |
FRESENIUS KABI DEUTSCHLAND GMBH imports 278 distinct Oxaliplatin formulations from India. The top formulation is OXALIPLATIN KABI INJ.200MG/40ML VIAL B.N with 15 shipments worth $607.6K.
Regulatory Requirements: Importing Oxaliplatin into Germany
What FRESENIUS KABI DEUTSCHLAND GMBH and other importers must comply with to import Oxaliplatin from India
Regulatory Authority
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Approval Process for Generic Oxaliplatin
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
GMP Requirements
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
Import Licence & Documentation
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
Labeling & Packaging
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Oxaliplatin from India and How Much Does FRESENIUS KABI DEUTSCHLAND GMBH Import?
India exported $20.7M worth of Oxaliplatin through 3,081 shipments from 249 suppliers to 123 countries, serving 693 buyers globally. FRESENIUS KABI DEUTSCHLAND GMBH imports $9.0M of this total, accounting for 21.5% of India's Oxaliplatin exports with 362 shipments from GERMANY. This is verified from 362 customs shipment records covering 278 distinct formulations.
What Is the Average Order Value for FRESENIUS KABI DEUTSCHLAND GMBH's Oxaliplatin Imports?
FRESENIUS KABI DEUTSCHLAND GMBH's average Oxaliplatin order value is $24.9K per consignment, based on 362 shipments totaling $9.0M. FRESENIUS KABI DEUTSCHLAND GMBH is based in GERMANY and ranks #1 among all Oxaliplatin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Oxaliplatin to FRESENIUS KABI DEUTSCHLAND GMBH?
FRESENIUS KABI DEUTSCHLAND GMBH sources Oxaliplatin from 1 verified Indian supplier: FRESENIUS KABI ONCOLOGY LIMITED ($9.0M, 100.0%). This is based on 362 customs records.
How Does FRESENIUS KABI DEUTSCHLAND GMBH Compare to Other Oxaliplatin Importers?
FRESENIUS KABI DEUTSCHLAND GMBH ranks #1 among 693 Oxaliplatin importers from India with a 21.5% market share. The top 3 importers are FRESENIUS KABI DEUTSCHLAND GMBH ($10.0M), PHARMACIE CENTRALE DES HOPITAUX ($2.3M), YUSEN LOGISTICS BENELUX BELGIUM ($2.2M). FRESENIUS KABI DEUTSCHLAND GMBH processed 362 shipments from GERMANY.
What Other Advanced Oncology Products Does FRESENIUS KABI DEUTSCHLAND GMBH Import?
FRESENIUS KABI DEUTSCHLAND GMBH also imports these advanced oncology products. Each links to the detailed product page.
About FRESENIUS KABI DEUTSCHLAND GMBH
FRESENIUS KABI DEUTSCHLAND GMBH imports 10 products worth $65.5M. Beyond Oxaliplatin, top products include Paclitaxel, Carboplatin, Pemetrexed, Irinotecan, Docetaxel. View the complete FRESENIUS KABI DEUTSCHLAND GMBH profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Oxaliplatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Oxaliplatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: FRESENIUS KABI DEUTSCHLAND GMBH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as FRESENIUS KABI DEUTSCHLAND GMBH's capped import value divided by total capped export value for Oxaliplatin across all Indian exporters.
- 5.Verified Records: This page is backed by 362 individual customs records matching FRESENIUS KABI DEUTSCHLAND GMBH importing Oxaliplatin, covering 278 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 123+ countries, 693+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Oxaliplatin Import Data for FRESENIUS KABI DEUTSCHLAND GMBH
Access order-level details, pricing data, supplier connections, and competitive analysis for FRESENIUS KABI DEUTSCHLAND GMBH's Oxaliplatin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FRESENIUS KABI DEUTSCHLAND GMBH
Full Company Profile →
10 products · $65.5M total trade · 2 categories
FRESENIUS KABI DEUTSCHLAND GMBH × Oxaliplatin
Verified from customs records
Company Overview
Top Products by FRESENIUS KABI DEUTSCHLAND GMBH
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for FRESENIUS KABI DEUTSCHLAND GMBH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Oxaliplatin. For current order-level data, contact TransData Nexus.